Skip to content
Clinical Trials – home

Hospital Pedro Hispano

Verified siteinfo

Portugal Rua Doutor Eduardo Torres 1, 4450-113 Matosinhos, Portugal

  • 12 trials recruiting
  • Chronic inflammatory demyelinating polyradiculoneuropathy · Idiopathic pulmonary fibrosis · Multiple sclerosis
  • Adult patients

About Specializations

Hospital Pedro Hispano in Matosinhos, Portugal specialises in clinical trials of conditions such as Chronic inflammatory demyelinating polyradiculoneuropathy, Idiopathic pulmonary fibrosis, Multiple sclerosis, Partial seizures, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases Research

At Hospital Pedro Hispano, clinical trials in immune system diseases focus on understanding and improving care for conditions that affect the body’s defenses. The research is centered on evaluating new treatment options and measuring how well they can support patients over time.

  • Studies in immune system diseases and related inflammatory conditions
  • Research aimed at testing treatment effectiveness and long-term tolerability

One key area of interest is chronic inflammatory neuropathy, where investigators are assessing whether new therapies can offer safer and more durable disease control for patients.

Nervous System Diseases Research

Clinical research at this hospital also includes nervous system diseases, with a strong focus on progressive neurological disorders. These trials are designed to help improve treatment options for patients living with conditions that can gradually affect movement, function, and quality of life.

  • Primary Progressive Multiple Sclerosis studies
  • Trials exploring new therapies to delay disability progression

The work being done in Matosinhos is helping evaluate whether emerging treatments can slow disease worsening and provide better long-term outcomes for people with multiple sclerosis.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Rua Doutor Eduardo Torres 14450-113 MatosinhosPortugal
Recruiting now
12 trials
Conditions studied
30
Partner status
Verified site

More sites in MatosinhosPortugal

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

27 clinical trials

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:BHV-7000
  • Sponsor:Biohaven Therapeutics Ltd.

A study to evaluate the safety and efficacy of ivosidenib, decitabine, and cedazuridine in adults with newly diagnosed acute myeloid leukemia who are older than 60 or cannot receive intensive chemotherapy.

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Cedazuridine
  • Sponsor:Fundacion PETHEMA

Study of alteplase and tenecteplase for intravenous thrombolysis in patients with ischemic stroke who are taking direct oral anticoagulants

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:Insel Gruppe AG

Study of Saccharomyces boulardii CNCM I-745 to treat symptoms in adults with non-constipated Irritable Bowel Syndrome

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Loperamide Hydrochloride
  • Sponsor:Biocodex

Study on the Safety and Effects of DNL593 for Patients with Frontotemporal Dementia

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:DNL593
  • Sponsor:Denali Therapeutics Inc.

Study on Long-term Safety and Efficacy of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Riliprubart
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on Frexalimab, SAR442970, and Rilzabrutinib for Patients Aged 16-75 with Focal Segmental Glomerulosclerosis or Minimal Change Disease

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Pneumonia

Recruiting

Study on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Baloxavir Marboxil
  • Sponsor:University Of Oxford

Study Comparing MK-2870 and Pembrolizumab Combination to Pembrolizumab Alone for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Merck Sharp & Dohme LLC

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Teriflunomide
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on BI 764532 for Patients with Relapsed or Refractory Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:BI 764532
  • Sponsor:Boehringer Ingelheim International GmbH
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.